Evidence map›Paper›PMID 10627290›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2000

Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors.

A M Norfleet, C H Clarke, B Gametchu, C S Watson

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 129 citations in OpenAlex.

  1. Review
  2. Article
  3. Exploration of the Effects of TGF-Contrast media & molecular imaging · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Non-genomic effects of xenoestrogen mixtures.International journal of environmental research and public health · 2012
    Review
  10. Article
  11. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways.The Journal of steroid biochemistry and molecular biology · 2011
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2008
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

A M NorfleetDepartment of Human Biological Chemistry, University of Texas Medical Branch, Galveston, TX 77555, USA.
C H Clarke
B Gametchu
C S Watson
Center for Human Genetics · USMedical College of Wisconsin · USTexas Medical Center · US

Funding

REPRODUCTIVE FUNCTION OF MEMBRANE ESTROGEN RECEPTORSR01HD032481 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WATSON, CHERYL S · 1995 to 1998
–
NICHD NIH HHS HD32481NICHD NIH HHS R01 HD032481-04
6 · The paper itself

Abstract

Antibodies (Abs) raised against the estrogen receptor-alpha (ERalpha) were used to investigate the role of ERalpha proteins located at the plasma membrane in mediating the rapid, estrogen-stimulated secretion of prolactin (PRL) from rat pituitary GH(3)/B6/F10 cells. Exposure of the cells to 1 nM 17beta-estradiol (E(2)) significantly increased PRL release after 3 or 6 min. When ERalpha Abs that bind specifically to ERalpha but are too large to diffuse into cells were tested for activity at the cell membrane, Ab R4, targeted to an ERalpha hinge region sequence, increased PRL release in a time- and concentration-dependent fashion. Ab H151, directed against a different hinge region epitope, decreased PRL release and blocked the stimulatory action of E(2). Abs raised against the DNA binding domain (H226) or the carboxyl terminus (C542) were not biologically active. When each Ab was examined for recognition of ERalpha on the cell surface by immunocytochemistry, all except H151 generated immunostaining in aldehyde-fixed cells. In live cells, however, Ab H151 but not Ab R4 blocked the membrane binding of fluorescently tagged E(2)-BSA. Overall, the data indicate that plasma membrane ERalpha proteins mediate estrogen-stimulated PRL release from GH(3)/B6/F10 cells. These results may also convey information about conformationally sensitive areas of the membrane form of ERalpha involved in rapid, nongenomic responses to estrogens.

Indexed as

Amino Acid SequenceAnimalsAntibodiesCell LineCell MembraneEstrogen Receptor alphaMembrane ProteinsMolecular Sequence DataPituitary NeoplasmsProlactinRatsReceptors, EstrogenAntibodiesEstrogen Receptor alphaMembrane ProteinsProlactinReceptors, Estrogen

Identifiers

PMID10627290
PMCPMC1189731
OpenAlexW1543854743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.